Misplaced Pages

#851148

71-416: Some bacteria contain multiple copies of the 16S rRNA gene, which is commonly used as the molecular marker to study phylogeny . In these cases, the single-copy rpoB gene can be used to study microbial diversity. An inhibitor of transcription in bacteria, tagetitoxin , also inhibits PEP, showing that the complex found in plants is very similar to the homologous enzyme in bacteria. In a bacterium without

142-437: A C. AGAGTTTGATC M TGGCTCAG compared with 8F. In addition to highly conserved primer binding sites, 16S rRNA gene sequences contain hypervariable regions that can provide species-specific signature sequences useful for identification of bacteria. As a result, 16S rRNA gene sequencing has become prevalent in medical microbiology as a rapid and cheap alternative to phenotypic methods of bacterial identification. Although it

213-444: A growing number of observations suggest the occurrence of horizontal transfer of these genes. In addition to observations of natural occurrence, transferability of these genes is supported experimentally using a specialized Escherichia coli genetic system. Using a null mutant of E. coli as host, growth of the mutant strain was shown to be complemented by foreign 16S rRNA genes that were phylogenetically distinct from E. coli at

284-715: A lower than normal level. In M. tuberculosis mutations in the rpoB gene can significantly upregulate polyketide synthase , potentially indicating increased production of phthiocerol dimycocerosate, a lipid produced by M. tuberculosis and implicated in virulence of the bacteria. Mutations also impact promoter binding, elongation, termination, and transcription-coupled repair processes in the RNA polymerase itself. Because of this, rpoB mutations were used to study transcription mechanisms before interest shifted to their ability to impart antibiotic resistance. Particular mutations can even result in strains of M. tuberculosis which grow better in

355-588: A relatively low loss of fitness. For Staphylococcus aureus , the rifamycin-resistant mutation most commonly encountered involves codon 526. In addition to imparting resistance to rifampicin, certain rpoB mutations have been identified in 70% of Vancomycin Intermediate S. aureus (VISA) strains. The regions of the rpoB gene which are susceptible to mutations are typically well conserved, indicating they are important for life. This makes it very likely that mutations within these regions have some effect on

426-399: A suite of search, primer-design and alignment tools (Bacteria, Archaea and Eukarya). GreenGenes is a quality controlled, comprehensive 16S rRNA gene reference database and taxonomy based on a de novo phylogeny that provides standard operational taxonomic unit sets. Beware that it utilizes taxonomic terms proposed from phylogenetic methods applied years ago between 2012 and 2013. Since then,

497-557: A variety of novel phylogenetic methods have been proposed for Archaea and Bacteria. Vancomycin Vancomycin is a glycopeptide antibiotic medication used to treat certain bacterial infections . It is administered intravenously ( injection into a vein ) to treat complicated skin infections , bloodstream infections , endocarditis , bone and joint infections, and meningitis caused by methicillin-resistant Staphylococcus aureus . Blood levels may be measured to determine

568-414: Is 500 mg every 6 hours or 1000 mg every 12 hours, with modification to achieve a therapeutic range as needed. The recommended oral dosage in the treatment of antibiotic-induced pseudomembranous enterocolitis is 125 to 500 mg every 6 hours for 7 to 10 days. Dose optimization and target attainment of vancomycin in children involves adjusting the dosage to maximize effectiveness while minimizing

639-434: Is a curated database that offers ribosome data along with related programs and services. The offerings include phylogenetically ordered alignments of ribosomal RNA (rRNA) sequences, derived phylogenetic trees, rRNA secondary structure diagrams and various software packages for handling, analyzing and displaying alignments and trees. The data are available via ftp and electronic mail. Certain analytic services are also provided by

710-456: Is a last-resort medication for the treatment of sepsis and lower respiratory tract , skin, and bone infections caused by Gram-positive bacteria. The minimum inhibitory concentration susceptibility data for a few medically significant bacteria are: Common side effects associated with oral vancomycin administration (used to treat intestinal infections) include: Serum vancomycin levels may be monitored in an effort to reduce side effects, but

781-495: Is able to form hydrogen bond interactions with the terminal D -alanyl- D -alanine moieties of the NAM/NAG-peptides. Under normal circumstances, this is a five-point interaction. This binding of vancomycin to the D -Ala- D -Ala prevents cell wall synthesis of the long polymers of N -acetylmuramic acid (NAM) and N -acetylglucosamine (NAG) that form the backbone strands of the bacterial cell wall, and prevents

SECTION 10

#1732780834852

852-406: Is also used for dose optimization of vancomycin in treating children. Target ranges for serum vancomycin concentrations have changed over the years. Early authors suggested peak levels of 30 to 40 mg/L and trough levels of 5 to 10 mg/L, but current recommendations are that peak levels need not be measured and that trough levels of 10 to 15 mg/L or 15 to 20 mg/L, depending on

923-407: Is assembled through NRPS, the non-proteinogenic amino acids are first synthesized. L -tyrosine is modified to become the β-hydroxytyrosine (β-HT) and 4-hydroxyphenylglycine (4-Hpg) residues. 3,5 dihydroxyphenylglycine ring (3,5-DPG) is derived from acetate. Nonribosomal peptide synthesis occurs through distinct modules that can load and extend the protein by one amino acid per module through

994-738: Is considered time-dependent; that is, antimicrobial activity depends on how long the serum drug concentration exceeds the minimum inhibitory concentration of the target organism. Thus, peak serum levels have not been shown to correlate with efficacy or toxicity; indeed, concentration monitoring is unnecessary in most cases. Circumstances in which therapeutic drug monitoring is warranted include patients receiving concomitant aminoglycoside therapy, patients with (potentially) altered pharmacokinetic parameters, patients on haemodialysis , patients administered high-dose or prolonged treatment, and patients with impaired renal function. In such cases, trough concentrations are measured. Therapeutic drug monitoring

1065-421: Is in the treatment of pseudomembranous colitis, where it must be given orally to reach the site of infection in the colon. After oral administration, the fecal concentration of vancomycin is around 500 μg/mL (sensitive strains of Clostridioides difficile have a mean inhibitory concentration of ≤2 μg/mL ) Inhaled vancomycin can also be used off-label , via nebulizer , to treat various infections of

1136-561: Is likely safe for use when breastfeeding . It is a type of glycopeptide antibiotic and works by blocking the construction of a cell wall . Vancomycin was approved for medical use in the United States in 1958. It is on the World Health Organization's List of Essential Medicines . The WHO classifies vancomycin as critically important for human medicine. It is available as a generic medication. Vancomycin

1207-608: Is made by the soil bacterium Amycolatopsis orientalis . Vancomycin is indicated for the treatment of serious, life-threatening infections by Gram-positive bacteria of both aerobic and anaerobic types that are unresponsive to other antibiotics. The increasing emergence of vancomycin-resistant enterococci has resulted in the development of guidelines for use by the Centers for Disease Control Hospital Infection Control Practices Advisory Committee. These guidelines restrict use of vancomycin to these indications: Vancomycin

1278-539: Is most prevalent at the proximal tubule, which is further supported by urinary biomarkers, such as kidney injury molecule-1 (KIM-1), clusterin, and osteopontin (OPN). In humans, insulin-like growth factor binding protein 7 (IGFBP7) as part of the nephrocheck test. The mechanisms underlying the pathogenesis of vancomycin nephrotoxicity are multifactorial but include interstitial nephritis, tubular injury due to oxidative stress, and cast formation. Therapeutic drug monitoring can be used during vancomycin therapy to minimize

1349-414: Is of aerobic or anaerobic type. Specifically, vancomycin forms hydrogen bonds with the D -alanyl- D -alanine ( D -Ala- D -Ala) peptide motif of the peptidoglycan precursor, a crucial component of the bacterial cell wall. Peptidoglycan is a polymer that provides structural support to the bacterial cell wall. The peptidoglycan precursor is synthesized in the cytoplasm and then transported across

1420-487: Is often not validated. Therefore, secondary databases that collect only 16S rRNA sequences are widely used. MIMt is a compact non-redundant 16S database for a rapid metagenomic samples identification. It is composed of 39.940 full 16S sequences belonging to 17,625 well classified bacteria and archaea species. All sequences were obtained from complete genomes deposited in NCBI and for each of the sequences full taxonomic hierarchy

1491-544: Is provided. It contains no redundancy, so only one representative for each species was considered avoiding same sequences from differente strains, isolates or patovars resulting in a very fast tool for microorganisms identification, compatible with any classification software (QIIME, Mothur, DADA, etc). EzBioCloud database, formerly known as EzTaxon , consists of a complete hierarchical taxonomic system containing 62,988 bacteria and archaea species/phylotypes which includes 15,290 valid published names as of September 2018. Based on

SECTION 20

#1732780834852

1562-407: Is that clearly related cases of vancomycin ototoxicity are rare. The association between vancomycin serum levels and ototoxicity is also uncertain. Cases of ototoxicity have been reported in patients whose vancomycin serum level exceeded 80 μg/mL, but cases have also been reported in patients with therapeutic levels. Thus it remains unknown whether therapeutic drug monitoring of vancomycin for

1633-524: Is the RNA component of the 30S subunit of a prokaryotic ribosome ( SSU rRNA ). It binds to the Shine-Dalgarno sequence and provides most of the SSU structure. The genes coding for it are referred to as 16S rRNA genes and are used in reconstructing phylogenies , due to the slow rates of evolution of this region of the gene. Carl Woese and George E. Fox were two of the people who pioneered

1704-523: Is then transferred to the PCP domain with the expulsion of AMP. The PCP domain uses the attached 4'-phosphopantethein prosthetic group to load the growing peptide chain and their precursors. The organization of the modules necessary to biosynthesize vancomycin is shown in Figure 1. In the biosynthesis of vancomycin, additional modification domains are present, such as the epimerization (E) domain, which isomerizes

1775-439: The D -Ala- D -Ala peptide motif of the peptidoglycan precursor, thereby preventing its processing by the transglycosylase; as such, vancomycin disrupts the transglycosylation activity of the cell wall synthesis process. The disruption leads to an incomplete and corrupted cell wall, which makes the replicating bacteria vulnerable to external forces such as osmotic pressure, so that the bacteria cannot survive and are eliminated by

1846-565: The United States , vancomycin is approved by the Food and Drug Administration for intravenous and oral administration. Vancomycin must be given intravenously for systemic therapy since it is poorly absorbed from the intestine. It is a large hydrophilic molecule that partitions poorly across the gastrointestinal mucosa . Due to its short half-life, it is often injected twice daily. The only approved indication for oral vancomycin therapy

1917-402: The amide bond formation at the contact sites of the activating domains. Each module typically consists of an adenylation (A) domain, a peptidyl carrier protein (PCP) domain, and a condensation (C) domain. In the A domain, the specific amino acid is activated by converting into an aminoacyl adenylate enzyme complex attached to a 4'phosphopantetheine cofactor by thioesterification. The complex

1988-489: The annealing of "universal" primers . Mitochondrial and chloroplastic rRNA are also amplified. The most common primer pair was devised by Weisburg et al. (1991) and is currently referred to as 27F and 1492R; however, for some applications shorter amplicons may be necessary, for example for 454 sequencing with titanium chemistry the primer pair 27F-534R covering V1 to V3. Often 8F is used rather than 27F. The two primers are almost identical, but 27F has an M instead of

2059-552: The "Rifampicin Resistance Determining Region (RRDR)". This resistance is typically associated with a mutation wherein a base in the DNA is substituted for another one and the new sequence codes for an amino acid with a large side chain that inhibits the rifampicin molecules from binding to the polymerase. There are additional mutations which can occur in the β subunit of the polymerase which are located away from

2130-432: The 16S gene contains highly conserved sequences between hypervariable regions, enabling the design of universal primers that can reliably produce the same sections of the 16S sequence across different taxa . Although no hypervariable region can accurately classify all bacteria from domain to species, some can reliably predict specific taxonomic levels. Many community studies select semi-conserved hypervariable regions like

2201-433: The 1980s until 2008 recommended vancomycin trough concentrations between 5 and 15 μg/mL. Concern for treatment failures prompted recommendations for higher dosing (troughs 15 to 20 μg/mL) for serious infection, and acute kidney injury (AKI) rates attributable to the vancomycin increased. Importantly, the risk of AKI increases with co-administration of other known nephrotoxins, in particular aminoglycosides. Furthermore,

rpoB - Misplaced Pages Continue

2272-524: The NRPSs only contain 3 epimerization domains. The origin of D-Leu at residue 1 is unknown. The three peptide syntheses are at the start of the region of the bacterial genome linked with antibiotic biosynthesis, and span 27 kb. β-hydroxytyrosine (β-HT) is synthesized before incorporation into the heptapeptide backbone. L-tyrosine is activated and loaded on the NRPS VpsD, hydroxylated by OxyD, and released by

2343-552: The V3 region was best at identifying the genus for all pathogens tested, and that V6 was the most accurate at differentiating species between all CDC-watched pathogens tested, including anthrax . While 16S hypervariable region analysis is a powerful tool for bacterial taxonomic studies, it struggles to differentiate between closely related species. In the families Enterobacteriaceae , Clostridiaceae , and Peptostreptococcaceae , species can share up to 99% sequence similarity across

2414-652: The V4 for this reason, as it can provide resolution at the phylum level as accurately as the full 16S gene. While lesser-conserved regions struggle to classify new species when higher order taxonomy is unknown, they are often used to detect the presence of specific pathogens. In one study by Chakravorty et al. in 2007, the authors characterized the V1–V8 regions of a variety of pathogens in order to determine which hypervariable regions would be most useful to include for disease-specific and broad assays . Amongst other findings, they noted that

2485-676: The X domain in the 7th NRPS module, which is unique to glycopeptide antibiotic biosynthesis. The cross-linked heptapeptide is then released by the action of the TE domain, and methyltransferase Vmt then N -methylates the terminal leucine residue. GtfE then joins D-glucose to the phenolic oxygen of residue 4, followed by the addition of vancosamine catalyzed by GtfD. Some of the glycosyltransferases capable of glycosylating vancomycin and related nonribosomal peptides display notable permissivity and have been used to generate libraries of differentially glycosylated analogs through glycorandomization . Both

2556-469: The amino acid from one stereochemistry to another, and a thioesterase domain (TE) is used as a catalyst for cyclization and releases of the molecule via a thioesterase scission. A set of NRPS enzymes (peptide synthase VpsA, VpsB, and VpsC) are responsible for assembling the heptapeptide. (Figure 2). VpsA codes for modules 1, 2, and 3. VpsB codes for modules 4, 5, and 6, and VpsC codes for module 7. The vancomycin aglycone contains 4 D-amino acids, although

2627-599: The commencement or soon after the completion of an infusion and is characterized by flushing and/or an erythematous rash that affects the face, neck, and upper torso, attributed to the release of histamine from mast cells. This reaction is caused by the interaction of vancomycin with MRGPRX2 , a GPCR-mediating IgE-independent mast cell degranulation. Less frequently, hypotension and angioedema occur. Symptoms may be treated or prevented with antihistamines , including diphenhydramine , and are less likely to occur with slow infusion. The recommended intravenous dosage in adults

2698-416: The correct dose. Vancomycin is also taken orally (by mouth) to treat Clostridioides difficile infections . When taken orally, it is poorly absorbed. Common side effects include pain in the area of injection and allergic reactions . Occasionally, hearing loss , low blood pressure , or bone marrow suppression occur. Safety in pregnancy is not clear, but no evidence of harm has been found, and it

2769-500: The corresponding mutation in S. aureus results in bacteria barely able to survive. In Neisseria meningitidis rpoB mutations have been observed to increase expression of enzymes which are involved in metabolizing carbohydrates, as well as enzymes involved in the citric acid cycle and in transcription elongation. At the same time enzymes involved in ATP production, cell division, and lipid metabolism are all downregulated, or expressed at

2840-467: The cytoplasmic membrane to the periplasmic space, where it is assembled into the cell wall. The assembly process involves two enzymatic activities: transglycosylation and transpeptidation. Transglycosylation involves the polymerization of the peptidoglycan precursor into long chains, while transpeptidation involves the cross-linking of these chains to form a three-dimensional mesh-like structure. Vancomycin inhibits bacterial cell wall synthesis by binding to

2911-448: The electronic mail server. Due to its large size the RDP database is often used as the basis for bioinformatic tool development and creating manually curated databases. SILVA provides comprehensive, quality checked and regularly updated datasets of aligned small (16S/ 18S , SSU ) and large subunit ( 23S / 28S , LSU ) ribosomal RNA (rRNA) sequences for all three domains of life as well as

rpoB - Misplaced Pages Continue

2982-695: The entire 16S sequence allows for comparison of all hypervariable regions, at approximately 1,500 base pairs long it can be prohibitively expensive for studies seeking to identify or characterize diverse bacterial communities. These studies commonly utilize the Illumina platform , which produces reads at rates 50-fold and 12,000-fold less expensive than 454 pyrosequencing and Sanger sequencing , respectively. While cheaper and allowing for deeper community coverage, Illumina sequencing only produces reads 75–250 base pairs long (up to 300 base pairs with Illumina MiSeq), and has no established protocol for reliably assembling

3053-417: The frequency of the latter may be much higher than previously thought. The 16S rRNA gene is used as the standard for classification and identification of microbes, because it is present in most microbes and shows proper changes. Type strains of 16S rRNA gene sequences for most bacteria and archaea are available on public databases, such as NCBI . However, the quality of the sequences found on these databases

3124-409: The full 16S gene. As a result, the V4 sequences can differ by only a few nucleotides , leaving reference databases unable to reliably classify these bacteria at lower taxonomic levels. By limiting 16S analysis to select hypervariable regions, these studies can fail to observe differences in closely related taxa and group them into single taxonomic units, therefore underestimating the total diversity of

3195-403: The full gene in community samples. Full hypervariable regions can be assembled from a single Illumina run, however, making them ideal targets for the platform. While 16S hypervariable regions can vary dramatically between bacteria, the 16S gene as a whole maintains greater length homogeneity than its eukaryotic counterpart ( 18S ribosomal RNA ), which can make alignments easier. Additionally,

3266-442: The immune system. Gram-negative bacteria are insensitive to vancomycin due to their different cell wall morphology. The outer membrane of Gram-negative bacteria contains lipopolysaccharide, which acts as a barrier to vancomycin penetration. That is why vancomycin is mainly used to treat infections caused by Gram-positive bacteria (except some nongonococcal species of Neisseria ). The large hydrophilic molecule of vancomycin

3337-738: The kidneys ( nephrotoxicity ) and to the hearing ( ototoxicity ) were side effects of the early, impure versions of vancomycin, and were prominent in clinical trials conducted in the mid-1950s. Later trials using purer forms of vancomycin found nephrotoxicity is an infrequent adverse effect (0.1% to 1% of patients), but this is accentuated in the presence of aminoglycosides . Rare adverse effects associated with intravenous vancomycin (<0.1% of patients) include anaphylaxis , toxic epidermal necrolysis , erythema multiforme , superinfection , thrombocytopenia , neutropenia , leukopenia , tinnitus , dizziness and/or ototoxicity , and DRESS syndrome . Vancomycin can induce platelet-reactive antibodies in

3408-430: The linear heptapeptide to cross-linked, glycosylated vancomycin, six enzymes are required. The enzymes OxyA, OxyB, OxyC, and OxyD are cytochrome P450 enzymes. OxyB catalyzes oxidative cross-linking between residues 4 and 6, OxyA between residues 2 and 4, and OxyC between residues 5 and 7. This cross-linking occurs while the heptapeptide is covalently bound to the PCP domain of the 7th NRPS module. These P450s are recruited by

3479-551: The nature of the infection and the specific patient's needs, may be appropriate. Measuring vancomycin concentrations to calculate doses optimizes therapy in patients with augmented renal clearance . Vancomycin is a branched tricyclic glycosylated nonribosomal peptide produced by the Actinomycetota species Amycolatopsis orientalis (formerly designated Nocardia orientalis ). Vancomycin exhibits atropisomerism —it has multiple chemically distinct rotamers owing to

3550-598: The nephrotoxic effect probably increases when vancomycin is added to nephrotoxins such as aminoglycosides. A dose- or serum level-effect relationship has not been established. Vancomycin is recommended to be administered in a dilute solution slowly, over at least 60 min (maximum rate of 10 mg/min for doses >500 mg) due to the high incidence of pain and thrombophlebitis and to avoid an infusion reaction known as vancomycin flushing reaction. This phenomenon has been often clinically referred to as "red man syndrome". The reaction usually appears within 4 to 10 min after

3621-400: The overall fitness of the organism. These physiological changes can include a reduced rate of growth, increased sensitivity to increases or decreases in temperature, and alterations to the properties of RNA chain elongation and transcription termination. Such changes are not universal across all bacteria, though. A mutation in codon 450 of M. tuberculosis leads to a minor loss of fitness, while

SECTION 50

#1732780834852

3692-476: The patient, leading to severe thrombocytopenia and bleeding with florid petechial hemorrhages , ecchymoses , and wet purpura . Historically, vancomycin has been considered a nephrotoxic and ototoxic drug, based on numerous case reports in the medical literature following initial approval by the FDA in 1958. But as its use increased with the spread of MRSA beginning in the 1970s, toxicity risks were reassessed. With

3763-442: The phylogenetic relationship such as maximum-likelihood and OrthoANI, all species/subspecies are represented by at least one 16S rRNA gene sequence. The EzBioCloud database is systematically curated and updated regularly which also includes novel candidate species. Moreover, the website provides bioinformatics tools such as ANI calculator, ContEst16S and 16S rRNA DB for QIIME and Mothur pipeline. ^^ The Ribosomal Database Project (RDP)

3834-490: The phylum level. Such functional compatibility was also seen in Thermus thermophilus . Furthermore, in T. thermophilus , both complete and partial gene transfer was observed. Partial transfer resulted in spontaneous generation of apparently random chimera between host and foreign bacterial genes. Thus, 16S rRNA genes may have evolved through multiple mechanisms, including vertical inheritance and horizontal gene transfer ;

3905-419: The presence of rifampicin than they do when the antibiotic is not present. In bacteria which are used to produce naturally occurring antibiotics such as erythromycin ( Saccharopolyspora erythraea ) and vancomycin ( Amycolatopsis orientalis ) certain rpoB mutations can increase the production of antibiotic by bacteria with those mutations. 16S rRNA 16 S ribosomal RNA (or 16 S rRNA )

3976-700: The proper mutation(s) in rpoB rifampicin binds to a site near the fork in the β subunit and prevents the polymerase from transcribing more than two or three base pairs of any RNA sequence and stopping production of proteins within the cell. Bacteria with mutations in the proper loci along the rpoB gene are resistant to this effect. Initial studies were done by Jin and Gross to generate rpoB mutations in E. coli that conferred resistance to rifampicin. Three clusters of mutations were identified, cluster I at codons 507-533, cluster II at codons 563-572, and cluster III at codon 687. The majority of these mutations are located within an 81 base pair(bp) region in cluster I dubbed

4047-433: The purpose of maintaining "therapeutic" levels prevents ototoxicity. Still, therapeutic drug monitoring can be used during vancomycin therapy to minimize the risk of ototoxicity associated with excessive drug exposure. Another area of controversy and uncertainty is whether and to what extent vancomycin increases the toxicity of other nephrotoxins. Clinical studies have yielded various results, but animal models indicate that

4118-468: The removal of impurities present in earlier formulations of the drug, and with the introduction of therapeutic drug monitoring , the risk of severe toxicity has been reduced. The extent of nephrotoxicity for vancomycin remains controversial. In 1980s, vancomycin with a purity > 90% was available, and kidney toxicity defined by an increase in serum creatinine of at least 0.5 mg/dL occurred in only about 5% of patients. But dosing guidelines from

4189-574: The rifampicin binding site that can also result in mild resistance. Potentially indicating that the shape of these areas may affect the formation of the rifampicin binding site. Nucleic acid probes can detect mutations in rpoB that confer rifampicin resistance. For Mycobacterium tuberculosis , the rifamycin-resistant mutations most commonly encountered involve codons 516, 526, and 531 (numbered, by convention, as in Escherichia coli rpoB ). These mutations result in high rifampicin resistance with

4260-525: The risk of adverse effects, specifically acute kidney injury. Dose optimization is achieved by therapeutic drug monitoring (TDM), which allows measurement of vancomycin levels in the blood. TDM using area under the curve (AUC)-guided dosing, preferably with Bayesian forecasting, is recommended to ensure that the AUC0-24h/minimal inhibitory concentration (MIC) ratio is maintained above a certain threshold (400-600) associated with optimal efficacy. In

4331-446: The risk of nephrotoxicity associated with excessive drug exposure. Immunoassays are commonly utilized for measuring vancomycin levels. In children, concomitant administration of vancomycin and piperacillin/tazobactam has been associated with an elevated incidence of AKI relative to other antibiotic regimens. Attempts to establish rates of vancomycin-induced ototoxicity are even more difficult due to lack of good data. The consensus

SECTION 60

#1732780834852

4402-428: The rotational restriction of some of the bonds. The form present in the drug is the thermodynamically more stable conformer . Vancomycin is made by the soil bacterium Amycolatopsis orientalis . Vancomycin biosynthesis occurs primarily via three nonribosomal protein syntheses (NRPSs) VpsA, VpsB, and VpsC. The enzymes determine the amino acid sequence during its assembly through its 7 modules. Before vancomycin

4473-628: The sample. Furthermore, bacterial genomes can house multiple 16S genes, with the V1, V2, and V6 regions containing the greatest intraspecies diversity. While not the most precise method of classifying bacterial species, analysis of the hypervariable regions remains one of the most useful tools available to bacterial community studies. Under the assumption that evolution is driven by vertical transmission , 16S rRNA genes have long been believed to be species-specific, and infallible as genetic markers inferring phylogenetic relationships among prokaryotes . However,

4544-441: The sensitivity of 16S NGS. The bacterial 16S gene contains nine hypervariable regions (V1–V9), ranging from about 30 to 100 base pairs long, that are involved in the secondary structure of the small ribosomal subunit . The degree of conservation varies widely between hypervariable regions, with more conserved regions correlating to higher-level taxonomy and less conserved regions to lower levels, such as genus and species. While

4615-455: The sort of infections treated with vancomycin may also cause AKI, and sepsis is the most common cause of AKI in critically ill patients. Finally, studies in humans are mainly associations studies, where the cause of AKI is usually multifacotorial. Animal studies have demonstrated that higher doses and longer duration of vancomycin exposure correlates with increased histopathologic damage and elevations in urinary biomarkers of AKI.37-38 Damage

4686-460: The thioesterase Vhp. The timing of the chlorination by halogenase VhaA during biosynthesis is undetermined, but is proposed to occur before the complete assembly of the heptapeptide. After the linear heptapeptide molecule is synthesized, vancomycin must undergo further modifications, such as oxidative cross-linking and glycosylation , in trans by distinct enzymes, referred to as tailoring enzymes, to become biologically active (Figure 3). To convert

4757-466: The upper and lower respiratory tract. Rectal administration is an off-label use of vancomycin for the treatment of Clostridioides difficile infection. Plasma level monitoring of vancomycin is necessary due to the drug's biexponential distribution, intermediate hydrophilicity, and potential for ototoxicity and nephrotoxicity, especially in populations with poor renal function and/or increased propensity to bacterial infection. Vancomycin activity

4828-659: The use of 16S rRNA in phylogenetics in 1977. Multiple sequences of the 16S rRNA gene can exist within a single bacterium . The 16S rRNA gene is used for phylogenetic studies as it is highly conserved between different species of bacteria and archaea. Carl Woese pioneered this use of 16S rRNA in 1977. It is suggested that 16S rRNA gene can be used as a reliable molecular clock because 16S rRNA sequences from distantly related bacterial lineages are shown to have similar functionalities. Some thermophilic archaea (e.g. order Thermoproteales ) contain 16S rRNA gene introns that are located in highly conserved regions and can impact

4899-417: The value of such monitoring has been questioned. Peak and trough levels are usually monitored, and for research purposes the area under the concentration curve is also sometimes used. Toxicity is best monitored by looking at trough values. Immunoassays are commonly used to measure vancomycin levels. Common adverse drug reactions (≥1% of patients) associated with intravenous vancomycin include: Damage to

4970-564: The vancomycin aglycone and the complete vancomycin molecule have been targets successfully reached by total synthesis . The target was first achieved by David Evans in October 1998, KC Nicolaou in December 1998, Dale Boger in 1999, and more selectively synthesized again by Boger in 2020. Vancomycin targets bacterial cell wall synthesis by binding to the basic building block of the bacterial cell wall of Gram-positive bacteria, whether it

5041-737: Was originally used to identify bacteria, 16S sequencing was subsequently found to be capable of reclassifying bacteria into completely new species , or even genera . It has also been used to describe new species that have never been successfully cultured. With third-generation sequencing coming to many labs, simultaneous identification of thousands of 16S rRNA sequences is possible within hours, allowing metagenomic studies, for example of gut flora . In samples collected from patients with confirmed infections, 16S rRNA next-generation sequencing (NGS) demonstrated enhanced detection in 40% of cases compared to traditional culture methods; moreover, pre-sampling antibiotic consumption did not significantly affect

#851148